Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Warren Olanow

Showing results (41-50 of 189) with videos related to

Pageof 19
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|August 12, 2009
Is Parkinson's disease a prion disorder?C Warren Olanow, Stanley B Prusiner
Clinical Neuropharmacology|October 3, 2007
Tolcapone: an efficacy and safety review (2007)C Warren Olanow, Paul B Watkins
Experimental Neurology|September 25, 2007
Regulatable promoters and gene therapy for Parkinson's disease: is the only thing to fear, fear itself?Jeffrey H Kordower, C Warren Olanow
Proceedings of the National Academy of Sciences of the United States of America|June 2, 2016
Fetal grafts for Parkinson's disease: Decades in the makingJeffrey H Kordower, C Warren Olanow
Movement Disorders : Official Journal of the Movement Disorder Society|February 21, 2017
Targeting α-Synuclein as a therapy for Parkinson's disease: The battle beginsC Warren Olanow, Jeffrey H Kordower
Annals of Neurology|October 23, 2009
Modeling Parkinson's diseaseC Warren Olanow, Jeffrey H Kordower
Experimental Neurology|November 18, 2017
Translating scientific advances into disease-modifying therapies for Parkinson's DiseaseM Angela Cenci, C Warren Olanow
Current Opinion in Neurology|July 9, 2005
Stem cell treatment for Parkinson's disease: an update for 2005Brian J Snyder, C Warren Olanow
Movement Disorders : Official Journal of the Movement Disorder Society|February 27, 2010
A changing journal for a changing fieldJose A Obeso, C Warren Olanow
Annals of Neurology|January 8, 2009
Parkinson's disease: unresolved issuesC Warren Olanow, Matthew B Stern
Pageof 19

Showing results (41-50 of 189) with videos related to

Sort By:
Pageof 19
Proceedings of the National Academy of Sciences of the United States of America|August 12, 2009
Is Parkinson's disease a prion disorder?C Warren Olanow, Stanley B Prusiner
Clinical Neuropharmacology|October 3, 2007
Tolcapone: an efficacy and safety review (2007)C Warren Olanow, Paul B Watkins
Experimental Neurology|September 25, 2007
Regulatable promoters and gene therapy for Parkinson's disease: is the only thing to fear, fear itself?Jeffrey H Kordower, C Warren Olanow
Proceedings of the National Academy of Sciences of the United States of America|June 2, 2016
Fetal grafts for Parkinson's disease: Decades in the makingJeffrey H Kordower, C Warren Olanow
Movement Disorders : Official Journal of the Movement Disorder Society|February 21, 2017
Targeting α-Synuclein as a therapy for Parkinson's disease: The battle beginsC Warren Olanow, Jeffrey H Kordower
Annals of Neurology|October 23, 2009
Modeling Parkinson's diseaseC Warren Olanow, Jeffrey H Kordower
Experimental Neurology|November 18, 2017
Translating scientific advances into disease-modifying therapies for Parkinson's DiseaseM Angela Cenci, C Warren Olanow
Current Opinion in Neurology|July 9, 2005
Stem cell treatment for Parkinson's disease: an update for 2005Brian J Snyder, C Warren Olanow
Movement Disorders : Official Journal of the Movement Disorder Society|February 27, 2010
A changing journal for a changing fieldJose A Obeso, C Warren Olanow
Annals of Neurology|January 8, 2009
Parkinson's disease: unresolved issuesC Warren Olanow, Matthew B Stern
Pageof 19